IL33 and idiopathic pulmonary fibrosis: Thus, multicenter, large cohort studies on the exact interactions between IL‐25/IL‐33/TSLP and different IPF phenotypes (e.g., mild or severe, stable state, or acute exacerbation) should be further conducted.